• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Elsevier, ACC launch new journal JACC: Heart Failure

Elsevier, ACC launch new journal JACC: Heart Failure

March 11, 2013
CenterWatch Staff

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the American College of Cardiology (ACC) have launched a new journal named JACC: Heart Failure. This journal will better meet the demands and challenges of treating what is now the most rapidly increasing category of cardiac disease. The first publication is now available here.

Christopher O'Connor, MD, FACC will serve as editor-in-chief of JACC: Heart Failure. Each bi-monthly issue will present high-quality content, authored by experts worldwide, with a unique focus on new research and treatment options. The journal intends to improve the understanding of the disease, clinical trials, clinical outcomes and advances in therapies through scientific communication.

A state-of-the-condition update by Dr. Eugene Braunwald and the breadth of articles featured in the first issue are an example of the journal's aims to publish the full range of topics related to this condition—including basic and translational science, trials and registries, co-morbidities, biomarkers, advanced heart failure and outcomes.

"The addition of JACC: Heart Failure to ACC's current portfolio will help meet the need for more research in this growing field," said William Zoghbi, MD, FACC, president of ACC. "With the increasing rate of patients suffering from heart failure, the science presented in this new journal will give cardiologists access to valuable new research."

Cynthia Baudendistel, executive publisher for the ACC journals, Elsevier, added, "We are delighted to be publishing JACC: Heart Failure in collaboration with the ACC. We look forward to seeing the impact this journal will make on cardiology practice, research, teaching, and advocacy."

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing